5921 related articles for article (PubMed ID: 3707060)
21. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
[TBL] [Abstract][Full Text] [Related]
22. Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
Stachtea X; Karamanos N; Klouras N
Anticancer Res; 2009 Aug; 29(8):3227-31. PubMed ID: 19661339
[TBL] [Abstract][Full Text] [Related]
23. [Toxicity and antitumoral activity of two new complex compounds of rhenium].
Natorkhin MI; Stukov AN; Filov VA
Vopr Onkol; 2002; 48(1):61-2. PubMed ID: 12101569
[TBL] [Abstract][Full Text] [Related]
24. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of titanocene amino acid complexes.
Köpf-Maier P; Tornieporth-Oetting IC
Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
[TBL] [Abstract][Full Text] [Related]
26. A search for new antitumor compounds. Biological studies. 3. Antitumor properties of 14 new acridine derivatives.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Peryt J; Hrabowska M; Konopa J; Balk M; Jereczek E
Arch Immunol Ther Exp (Warsz); 1967; 15(2):233-40. PubMed ID: 6050441
[No Abstract] [Full Text] [Related]
27. A search for new antitumor compounds. Biological studies. IV. Antitumor properties of 21 new acridine derivatives.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Bogucka M; Hrabowska M; Konopa J; Balk M; Jereczek E
Arch Immunol Ther Exp (Warsz); 1967; 15(2):241-8. PubMed ID: 6050442
[No Abstract] [Full Text] [Related]
28. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
29. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
30. Antitumor and antiproliferative effects of an aqueous extract from the marine diatom Haslea ostrearia (Simonsen) against solid tumors: lung carcinoma (NSCLC-N6), kidney carcinoma (E39) and melanoma (M96) cell lines.
Carbonnelle D; Pondaven P; Morancais M; Masse G; Bosch S; Jacquot C; Briand G; Robert J; Roussakis C
Anticancer Res; 1999; 19(1A):621-4. PubMed ID: 10226609
[TBL] [Abstract][Full Text] [Related]
31. Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety.
Wang L; Gou S; Chen Y; Liu Y
Bioorg Med Chem Lett; 2005 Jul; 15(14):3417-22. PubMed ID: 15953727
[TBL] [Abstract][Full Text] [Related]
32. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
Fodstad O; Aamdal S; Pihl A; Boyd MR
Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
[TBL] [Abstract][Full Text] [Related]
34. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
Valadares MC; Queiroz ML
Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
[TBL] [Abstract][Full Text] [Related]
35. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
36. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, chemical characterization and biological evaluation of new platinum (II)-sulfonamide complexes.
Craciunescu DG; Scarcia V; Furlani A; Parrondo Iglesias E; Ravalico L; Doadrio A
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):183-7. PubMed ID: 2334458
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
40. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
